Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-cycle regulators and cancer

A Kamb1

  • 1Myriad Genetics, Inc., Salt Lake City, UT 84108, USA.

Trends in Genetics : TIG
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Cell cycle regulators, like cyclin-dependent kinase inhibitors (p16), are crucial in cancer development. The P16 gene is frequently mutated in various cancers, highlighting its role as a tumor suppressor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput screen to identify and optimize NOT gate receptors for cell therapy.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2024
Same author

Human potassium channel genes: Molecular cloning and functional expression.

Molecular and cellular neurosciences·2009
Same author

A genetic selection method for expression products that induce apoptosis in adherent mammalian cell lines.

Apoptosis : an international journal on programmed cell death·2003
Same author

Exogenous peptide and protein expression levels using retroviral vectors in human cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2001
Same author

A simple method for statistical analysis of intensity differences in microarray-derived gene expression data.

BMC biotechnology·2001
Same author

Enrichment during transdominant genetic experiments using a flow sorter.

Cytometry·2001
Same journal

Beyond housekeeping: snRNA diversity, regulation, and human disease.

Trends in genetics : TIG·2026
Same journal

Rethinking mitochondrial metabolism: Intraindividual variability meets population constraints.

Trends in genetics : TIG·2026
Same journal

A role for epigenetics in rapid adaptation.

Trends in genetics : TIG·2026
Same journal

The myth of asexual fungi.

Trends in genetics : TIG·2026
Same journal

Rethinking molecular evolution through protein language model embeddings.

Trends in genetics : TIG·2026
Same journal

Co-transcriptional splicing: Distinct phases, mutual benefits, and basis for nuclear architecture.

Trends in genetics : TIG·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer is fundamentally a disease of uncontrolled cellular growth.
  • The cell cycle machinery plays a critical role in the development of cancer (tumorigenesis).

Purpose of the Study:

  • To highlight the role of cell-cycle regulators in human cancer.
  • To focus on cyclin-dependent kinase inhibitors, such as p16, as key factors in tumorigenesis.

Main Methods:

  • Review of recent discoveries in cell-cycle regulation and cancer.
  • Analysis of the significance of p16 as a tumor suppressor molecule.

Main Results:

  • Cell-cycle regulators are increasingly recognized as significant factors in human cancer.

Related Experiment Videos

  • The p16 protein, a cyclin-dependent kinase inhibitor, exhibits characteristics of a tumor suppressor.
  • The P16 gene is a notable target for mutations in both sporadic and hereditary cancers.

    • Conclusions:

    • p16 is a critical regulator of cell growth decisions and functions as a tumor suppressor.
    • Mutations in the P16 gene are implicated in the pathogenesis of various human cancers.